Settlement Agreements in the Life Sciences Tools & Services Industry
20 Contracts & Agreements
- 10x Genomics, Inc. (1 contract)
- Agilent Technologies Inc (1)
- Bio-Matrix Scientific Group, Inc. (4)
- Bio-Rad Laboratories (1)
- BioNano Genomics, Inc (1)
- Codex DNA, Inc. (2)
- Cytek BioSciences, Inc. (1)
- ECO SCIENCE SOLUTIONS, INC. (1)
- NEOGENOMICS INC (1)
- Personalis, Inc. (1)
- PRESSURE BIOSCIENCES INC (1)
- Repligen Corporation (4)
- Sotera Health Co (1)
- Settlement Agreement and First Amendment to Debentures dated December 30, 2024 (BioNano Genomics, Inc, Filed With SEC on January 3, 2025)
- Settlement and License Agreement, between Personalis, Inc. and Foresight Diagnostics, Inc., dated June 21, 2024 (Personalis, Inc., Filed With SEC on June 27, 2024)
- Settlement Agreement (Sotera Health Co, Filed With SEC on May 3, 2023)
- Settlement Agreement, dated as of July 11, 2022, by and between Inivata Limited and Clive Morris (NEOGENOMICS INC, Filed With SEC on July 18, 2022)
- Amendment to Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated April 19, 2022 (Bio-Matrix Scientific Group, Inc., Filed With SEC on May 18, 2022)
- Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated February 8, 2022 (Bio-Matrix Scientific Group, Inc., Filed With SEC on May 18, 2022)
- Settlement Agreement between Rivulet Media, Inc. and Geneva Roth Remark Holdings, Inc., dated February 8, 2022 (Bio-Matrix Scientific Group, Inc., Filed With SEC on February 17, 2022)
- Settlement and Patent Cross License Agreement, dated July (10x Genomics, Inc., Filed With SEC on July 27, 2021)
- Settlement, License, and Equity Issuance Agreement, by and between Becton, Dickinson and Company and Cytek Biosciences, Inc., dated October 5, 2020 (Cytek BioSciences, Inc., Filed With SEC on July 2, 2021)
- Confidential Settlement Agreement between the Registrant and New England Biolabs, Inc. dated September 20, 2017 (Codex DNA, Inc., Filed With SEC on June 14, 2021)
- Confidential Settlement Agreement between the Registrant and New England Biolabs, Inc. dated September 20, 2017 (Codex DNA, Inc., Filed With SEC on May 28, 2021)
- Debt Settlement and Purchase Agreement (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on February 4, 2021)
- Settlement Agreement and General Release (Bio-Rad Laboratories, Filed With SEC on November 7, 2014)
- Settlement Agreement and Release, effective as of December 26, 2013, by and between Pressure BioSciences, Inc. and Redwood Management LLC (PRESSURE BIOSCIENCES INC, Filed With SEC on January 2, 2014)
- SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE (Bio-Matrix Scientific Group, Inc., Filed With SEC on March 12, 2013)
- SETTLEMENT AND RELEASE AGREEMENT (Repligen Corporation, Filed With SEC on August 8, 2008)
- SETTLEMENT AGREEMENT AND RELEASES (Repligen Corporation, Filed With SEC on November 9, 2007)
- SETTLEMENT AGREEMENT AND GENERAL RELEASE (Agilent Technologies Inc, Filed With SEC on March 10, 2005)
- REGENTS/REPLIGEN SETTLEMENT AGREEMENT (Repligen Corporation, Filed With SEC on February 9, 2005)
- WELLSTAT/REPLIGEN SETTLEMENT AGREEMENT (Repligen Corporation, Filed With SEC on February 9, 2005)
